Most lately, it's been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in related parts as classical opioid receptors, it binds to the big range of endogenous opi… Read More

Elucidating the precise pharmacological mechanism of motion (MOA) of naturally developing compounds is often tough. Although Tarselli et al. (sixty) designed the first de novo synthetic pathway to conolidine and showcased that… Read More